[go: up one dir, main page]

GB201313983D0 - Inhibition of CXCR4 signalling in cancer immunotherapy - Google Patents

Inhibition of CXCR4 signalling in cancer immunotherapy

Info

Publication number
GB201313983D0
GB201313983D0 GB201313983A GB201313983A GB201313983D0 GB 201313983 D0 GB201313983 D0 GB 201313983D0 GB 201313983 A GB201313983 A GB 201313983A GB 201313983 A GB201313983 A GB 201313983A GB 201313983 D0 GB201313983 D0 GB 201313983D0
Authority
GB
United Kingdom
Prior art keywords
inhibition
cancer immunotherapy
cxcr4 signalling
cxcr4
signalling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201313983A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GB201313983A priority Critical patent/GB201313983D0/en
Publication of GB201313983D0 publication Critical patent/GB201313983D0/en
Priority to GB201320329A priority patent/GB201320329D0/en
Priority to CA2920377A priority patent/CA2920377A1/en
Priority to EP14777826.0A priority patent/EP3030322A2/en
Priority to PCT/IB2014/063706 priority patent/WO2015019284A2/en
Priority to JP2016532778A priority patent/JP2016527303A/en
Priority to US14/620,463 priority patent/US20150216843A1/en
Priority to US14/828,729 priority patent/US20150352208A1/en
Priority to US15/889,459 priority patent/US20180228894A1/en
Ceased legal-status Critical Current

Links

GB201313983A 2013-08-05 2013-08-05 Inhibition of CXCR4 signalling in cancer immunotherapy Ceased GB201313983D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB201313983A GB201313983D0 (en) 2013-08-05 2013-08-05 Inhibition of CXCR4 signalling in cancer immunotherapy
GB201320329A GB201320329D0 (en) 2013-08-05 2013-11-18 Inhibition of CXCR4 signalling in cancer immunotherapy
CA2920377A CA2920377A1 (en) 2013-08-05 2014-08-05 Inhibition of cxcr4 signaling in cancer immunotherapy
EP14777826.0A EP3030322A2 (en) 2013-08-05 2014-08-05 Inhibition of cxcr4 signaling in cancer immunotherapy
PCT/IB2014/063706 WO2015019284A2 (en) 2013-08-05 2014-08-05 Inhibition of cxcr4 signaling in cancer immunotherapy
JP2016532778A JP2016527303A (en) 2013-08-05 2014-08-05 Inhibition of CXCR4 signaling in cancer immunotherapy
US14/620,463 US20150216843A1 (en) 2013-08-05 2015-02-12 Inhibition of cxcr4 signaling in cancer immunotherapy
US14/828,729 US20150352208A1 (en) 2013-08-05 2015-08-18 Inhibition of cxcr4 signaling in cancer immunotherapy
US15/889,459 US20180228894A1 (en) 2013-08-05 2018-02-06 Inhibition of cxcr4 signaling in cancer immunotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201313983A GB201313983D0 (en) 2013-08-05 2013-08-05 Inhibition of CXCR4 signalling in cancer immunotherapy

Publications (1)

Publication Number Publication Date
GB201313983D0 true GB201313983D0 (en) 2013-09-18

Family

ID=49224169

Family Applications (2)

Application Number Title Priority Date Filing Date
GB201313983A Ceased GB201313983D0 (en) 2013-08-05 2013-08-05 Inhibition of CXCR4 signalling in cancer immunotherapy
GB201320329A Ceased GB201320329D0 (en) 2013-08-05 2013-11-18 Inhibition of CXCR4 signalling in cancer immunotherapy

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB201320329A Ceased GB201320329D0 (en) 2013-08-05 2013-11-18 Inhibition of CXCR4 signalling in cancer immunotherapy

Country Status (1)

Country Link
GB (2) GB201313983D0 (en)

Also Published As

Publication number Publication date
GB201320329D0 (en) 2014-01-01

Similar Documents

Publication Publication Date Title
IL289821A (en) Compositions and methods for immunotherapy
IL273090B (en) Methods and compositions for the treatment of cancer
SG11201507688VA (en) Compositions and methods for immunotherapy
IL245470B (en) Methods and compositions for sustained immunotherapy
EP2961419A4 (en) Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy
GB201312133D0 (en) Immunotherapy
SG11201508223YA (en) Treatment of cancer with dihydropyrazino-pyrazines
IL243235A0 (en) Compositions and methods for immunotherapy
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
SG11201510150VA (en) Immunotherapy composition and use thereof
GB201403083D0 (en) Treatment of cancer
GB201320329D0 (en) Inhibition of CXCR4 signalling in cancer immunotherapy
GB201322958D0 (en) Uses of oligouronates in cancer treatment
GB201322346D0 (en) Combination treatment of cancer
GB201318242D0 (en) Monitoring cancer recurrence and progression
GB201322347D0 (en) Treatment of cancer
GB201318742D0 (en) Treatment of cancer
GB201308529D0 (en) Treatment of cancer
GB201305020D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)